← Back to Search

Ultrasonography for Kidney Cancer

N/A
Waitlist Available
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial will test if using ultrasound to scan the kidneys can help detect cancer recurrence better than other imaging methods.

Eligible Conditions
  • Kidney Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Utility of Renal Ultrasonography (US) in the detection of abdominal recurrences
Secondary outcome measures
Radiation Burden

Trial Design

1Treatment groups
Experimental Treatment
Group I: UltrasonographyExperimental Treatment1 Intervention
Patient will be scheduled to undergo an additional US by a blinded sonographer within 4 weeks of their most recent cross-sectional imaging that indicated a recurrence
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasonography
2013
Completed Phase 4
~4320

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
461 Previous Clinical Trials
169,107 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma
2020. "Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04424472.
All > Renal Cell Carcinoma
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top